235 related articles for article (PubMed ID: 33353723)
1. Hybrid Imaging of Vascular Cognitive Impairment.
Frantellizzi V; Conte M; De Vincentis G
Semin Nucl Med; 2021 May; 51(3):286-295. PubMed ID: 33353723
[TBL] [Abstract][Full Text] [Related]
2. Neuroimaging in Vascular Cognitive Impairment and Dementia: A Systematic Review.
Frantellizzi V; Pani A; Ricci M; Locuratolo N; Fattapposta F; De Vincentis G
J Alzheimers Dis; 2020; 73(4):1279-1294. PubMed ID: 31929166
[TBL] [Abstract][Full Text] [Related]
3. Neuropathological diagnosis of vascular cognitive impairment and vascular dementia with implications for Alzheimer's disease.
Kalaria RN
Acta Neuropathol; 2016 May; 131(5):659-85. PubMed ID: 27062261
[TBL] [Abstract][Full Text] [Related]
4. Contribution of neuroimaging to the diagnosis of Alzheimer's disease and vascular dementia.
Román G; Pascual B
Arch Med Res; 2012 Nov; 43(8):671-6. PubMed ID: 23142262
[TBL] [Abstract][Full Text] [Related]
5. MarkVCID cerebral small vessel consortium: II. Neuroimaging protocols.
Lu H; Kashani AH; Arfanakis K; Caprihan A; DeCarli C; Gold BT; Li Y; Maillard P; Satizabal CL; Stables L; Wang DJJ; Corriveau RA; Singh H; Smith EE; Fischl B; van der Kouwe A; Schwab K; Helmer KG; Greenberg SM;
Alzheimers Dement; 2021 Apr; 17(4):716-725. PubMed ID: 33480157
[TBL] [Abstract][Full Text] [Related]
6. Neuroimaging in vascular cognitive impairment: a state-of-the-art review.
Heiss WD; Rosenberg GA; Thiel A; Berlot R; de Reuck J
BMC Med; 2016 Nov; 14(1):174. PubMed ID: 27806705
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic patterns of regional atrophy on MRI and regional cerebral blood flow change on SPECT in young onset patients with Alzheimer's disease, frontotemporal dementia and vascular dementia.
Varma AR; Adams W; Lloyd JJ; Carson KJ; Snowden JS; Testa HJ; Jackson A; Neary D
Acta Neurol Scand; 2002 Apr; 105(4):261-9. PubMed ID: 11939938
[TBL] [Abstract][Full Text] [Related]
8. The Additional Value of PET in the Assessment of Cerebral Small Vessel Disease.
Heiss WD
J Nucl Med; 2018 Nov; 59(11):1660-1664. PubMed ID: 29959217
[TBL] [Abstract][Full Text] [Related]
9. The use of positron emission tomography/magnetic resonance imaging in dementia: A literature review.
Lorking N; Murray AD; O'Brien JT
Int J Geriatr Psychiatry; 2021 Oct; 36(10):1501-1513. PubMed ID: 34490651
[TBL] [Abstract][Full Text] [Related]
10. Positron emission tomography for diagnosis of Alzheimer's disease and vascular dementia.
Mielke R; Heiss WD
J Neural Transm Suppl; 1998; 53():237-50. PubMed ID: 9700661
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis and management of vascular cognitive impairment and dementia.
Erkinjuntti T
J Neural Transm Suppl; 2002; (63):91-109. PubMed ID: 12597611
[TBL] [Abstract][Full Text] [Related]
12. Clinical impact of 11C-Pittsburgh compound-B positron emission tomography in addition to magnetic resonance imaging and single-photon emission computed tomography on diagnosis of mild cognitive impairment to Alzheimer's disease.
Kitajima K; Abe K; Takeda M; Yoshikawa H; Ohigashi M; Osugi K; Koyama H; Yamakado K
Medicine (Baltimore); 2021 Jan; 100(3):e23969. PubMed ID: 33545981
[TBL] [Abstract][Full Text] [Related]
13. Vascular dementia: still a debatable entity?
Loeb C; Meyer JS
J Neurol Sci; 1996 Nov; 143(1-2):31-40. PubMed ID: 8981295
[TBL] [Abstract][Full Text] [Related]
14. Imaging of neurodegenerative cognitive and behavioral disorders: practical considerations for dementia clinical practice.
Atri A
Handb Clin Neurol; 2016; 136():971-84. PubMed ID: 27430453
[TBL] [Abstract][Full Text] [Related]
15. Imaging discrepancies between magnetic resonance imaging and brain perfusion single-photon emission computed tomography in the diagnosis of Alzheimer's disease, and verification with amyloid positron emission tomography.
Yokoyama S; Kajiya Y; Yoshinaga T; Tani A; Hirano H
Psychogeriatrics; 2014 Jun; 14(2):110-7. PubMed ID: 24954834
[TBL] [Abstract][Full Text] [Related]
16. Role of inflammatory and hemostatic biomarkers in Alzheimer's and vascular dementia - A pilot study from a tertiary center in Northern India.
Vishnu VY; Modi M; Garg VK; Mohanty M; Goyal MK; Lal V; Mittal BR; Prabhakar S
Asian J Psychiatr; 2017 Oct; 29():59-62. PubMed ID: 29061429
[TBL] [Abstract][Full Text] [Related]
17. Clinical impact of (11)C-Pittsburgh compound-B positron emission tomography carried out in addition to magnetic resonance imaging and single-photon emission computed tomography on the diagnosis of Alzheimer's disease in patients with dementia and mild cognitive impairment.
Omachi Y; Ito K; Arima K; Matsuda H; Nakata Y; Sakata M; Sato N; Nakagome K; Motohashi N
Psychiatry Clin Neurosci; 2015 Dec; 69(12):741-51. PubMed ID: 26085054
[TBL] [Abstract][Full Text] [Related]
18. EEG Analysis and Spect Imaging in Alzheimer's Disease, Vascular Dementia and Mild Cognitive Impairment.
Radić B; Petrović R; Golubić A; Bilić E; Borovečki F
Psychiatr Danub; 2019 Mar; 31(1):111-115. PubMed ID: 30948698
[TBL] [Abstract][Full Text] [Related]
19. MRI-visible perivascular space location is associated with Alzheimer's disease independently of amyloid burden.
Banerjee G; Kim HJ; Fox Z; Jäger HR; Wilson D; Charidimou A; Na HK; Na DL; Seo SW; Werring DJ
Brain; 2017 Apr; 140(4):1107-1116. PubMed ID: 28335021
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
